Presentation TCT 2020 The HOST-Reduce-Polytech-ACS trial: Durable Polymer versus Biodegradable Polymer Drug-Eluting Stents after percutaneous coronary intervention in patients with Acute Coronary Syndrome Presenter: Hyo-Soo Kim October 17, 2020
Presentation EuroPCR 2017 Randomized Comparison of Everolimus-eluting Bioresorbable Vascular Scaffolds vs. Everolimus-eluting Metallic Stents in Patients with Coronary Artery Disease: 3-year Clinical Outcomes from ABSORB China Presenter: Runlin Gao May 17, 2017
Presentation Beyond Restenosis: Patients’ Preference for Drug-Eluting or Bare-Metal Stents February 13, 2017
Presentation 10-Year Clinical Outcome After Randomization to Sirolimus- or Paclitaxel-Eluting Coronary stents February 13, 2017
Presentation JIM 2016 Self- Apposing Stents in STEMI:The Stentys Experience Presenter: Roxana Mehran February 10, 2016
Presentation Impact of Thrombus Burden on Outcomes After Standard Versus Mesh-Covered Stents in AMI Presenter: Ricardo A. Costa November 30, 2014
Presentation TCT 2014 Comparison of Novel Zotarolimus-Eluting Cobalt-Chromium Stents and Everolimus-Eluting Platinum-Chromium Stents in Patients of the Randomized DUTCH PEERS Trial Presenting with___ Presenter: Marije L?wik September 16, 2014
Presentation TCT 2014 Long-term Clinical Outcomes in Real-World Patients with Acute Myocardial Infarction Receiving XIENCE V® Everolimus-Eluting Stents: Four-Year Results from the XIENCE V USA Study_ Presenter: Krishnankutty Sudhir September 16, 2014
Presentation TCT 2014 Comparison of everolimus-eluting and paclitaxel-eluting coronary stents in patients undergoing primary percutaneous coronary intervention: 5 year follow-up from the COMPARE I___ Presenter: Georgios Vlachojannis September 16, 2014
Presentation Invasive Management Without Stents in Selected ACS Patients with a Large Thrombus Burden: A Prospective Study of OCT-Guided Treatment Decisions Presenter: Geraud Souteyrand July 30, 2014
Presentation TCT 2013 Self-Expanding Stents Provide a Real Benefit During STEMI Intervention! Presenter: Gilles Montalescot October 31, 2013
Presentation TCT 2013 Mesh-Covered Stents Are Optimal Management Strategy for Thrombus! Presenter: Dariusz Dudek October 31, 2013
Presentation TCT 2013 Update on Device Therapy for STEMI: Stents and Thrombectomy/Embolic Protection Presenter: Praveen Chandra October 31, 2013
Presentation TCT 2013 Stents and Pharmacotherapy in STEMI: Anticipating HORIZONS-AMI II Presenter: Gregg Stone October 28, 2013
Presentation Heparin-bonded Covered Stents vs. BMS for Complex Femoro-popliteal Artery Lesions Presenter: Johannes Lammer July 16, 2013
Presentation Impact of Bivalirudin and Paclitaxel-Eluting Stents on Outcomes in Patients Undergoing Primary PCI of the LAD Presenter: Jochen W?hrle July 09, 2013
Presentation Clinical Outcomes with Drug-Eluting and Bare-Metal Stents in Patients with STEMI Presenter: T. Palmerini June 04, 2013
Presentation TCT 2013 The Impact Of First- versus Second-Generation Drug-Eluting Stents On Immediate- and Intermediate-Term Outcomes In A Complex ST-Segment Elevation Myocardial Infarction Population Presenter: Joshua Loh, Hironori Kitabata, Israel Barbash, Danny Dvir, Salem Badr, Rebecca Torguson, Kenneth Kent, Lowell Satler, William Suddath, Augusto Pichard, Ron Waksman January 31, 2013
Presentation Self-Expanding vs. Balloon-Expandable Stents in AMI: APPOSITION II Presenter: R.J. van Geuns December 16, 2012